These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 10495375

  • 1. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C.
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [Abstract] [Full Text] [Related]

  • 2. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M, Hayashi N, Igarashi A, Kitahara H, Maeguchi M, Mizuno A, Murata Y, Nogita T, Toda K, Tsuboi R, Ueki R, Yamada M, Yamazaki M, Matsuda T, Natsumeda Y, Takahashi K, Harada S.
    Eur J Dermatol; 2004 Oct; 14(4):247-54. PubMed ID: 15319158
    [Abstract] [Full Text] [Related]

  • 3. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2002 Oct; 12(1):38-49. PubMed ID: 11809594
    [Abstract] [Full Text] [Related]

  • 4. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS, Dutasteride Alopecia Research Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [Abstract] [Full Text] [Related]

  • 5. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J.
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [Abstract] [Full Text] [Related]

  • 6. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss.
    Whiting DA, Olsen EA, Savin R, Halper L, Rodgers A, Wang L, Hustad C, Palmisano J, Male Pattern Hair Loss Study Group.
    Eur J Dermatol; 2003 Nov; 13(2):150-60. PubMed ID: 12695131
    [Abstract] [Full Text] [Related]

  • 8. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM, García-Hernández MJ, Fernández-Crehuet JL.
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [Abstract] [Full Text] [Related]

  • 9. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA.
    Eur J Dermatol; 2001 May; 11(4):332-4. PubMed ID: 11399540
    [Abstract] [Full Text] [Related]

  • 10. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
    Kaufman KD, Rotonda J, Shah AK, Meehan AG.
    Eur J Dermatol; 2008 May; 18(4):400-6. PubMed ID: 18573712
    [Abstract] [Full Text] [Related]

  • 11. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W, Barboza Martínez J, Tsai TF, Katsuoka K, Kawashima M, Tsuboi R, Barnes A, Ferron-Brady G, Chetty D.
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [Abstract] [Full Text] [Related]

  • 12. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA, Whiting DA, Savin R, Rodgers A, Johnson-Levonas AO, Round E, Rotonda J, Kaufman KD, Male Pattern Hair Loss Study Group.
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK, Kim KM, Yoo EA, Sim WY, Chung BC.
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [Abstract] [Full Text] [Related]

  • 14. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ.
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [Abstract] [Full Text] [Related]

  • 15. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H, Kunte C.
    MMW Fortschr Med; 1999 Sep 16; 141(37):38-40. PubMed ID: 10897972
    [Abstract] [Full Text] [Related]

  • 16. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J.
    Eur J Dermatol; 2008 Sep 16; 18(4):407-11. PubMed ID: 18573713
    [Abstract] [Full Text] [Related]

  • 17. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, Savin RC, Tharp MD.
    J Am Acad Dermatol; 2004 Apr 16; 50(4):541-53. PubMed ID: 15034503
    [Abstract] [Full Text] [Related]

  • 18. Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women.
    Trüeb RM, Swiss Trichology Study Group.
    Dermatology; 2004 Apr 16; 209(3):202-7. PubMed ID: 15459533
    [Abstract] [Full Text] [Related]

  • 19. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH, Menefee E, Sanchez M, Kaufman KD.
    J Am Acad Dermatol; 2006 Jul 16; 55(1):71-4. PubMed ID: 16781295
    [Abstract] [Full Text] [Related]

  • 20. Finasteride treatment of female pattern hair loss.
    Iorizzo M, Vincenzi C, Voudouris S, Piraccini BM, Tosti A.
    Arch Dermatol; 2006 Mar 16; 142(3):298-302. PubMed ID: 16549704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.